Skip to main content

Want a detailed portfolio tracker?

BRIA
AMEX
$1.36

BrilliA Inc - Class A (BRIA)

BrilliA Inc. is an innovative biotechnology company dedicated to enhancing skin health and advancing regenerative medicine through cutting-edge solutions for wound healing. By harnessing proprietary technologies, BrilliA addresses significant unmet medical needs, aiming to improve patient quality of life. With a strong commitment to research and development, the company is well-positioned to transform scientific advancements into effective therapeutic products, solidifying its role as a leader in the dynamic healthcare landscape.
Website: https://brilliaincorporated.com
Target: $2.75 (+102.21%)

Market Cap

$39M

Forward P/E

12.50

P/E Ratio

12.77

Free Cash Flow Yield

-11.93%

Price Chart

Valuation
Market Cap$39M
P/E12.77
Forward P/E12.50
P/S0.61
P/B2.58
Profitability
Total Revenue (TTM)$64M
Gross Profit (TTM)$9.70M
EBITDA$4.58M
Profit Margin4.4%
Operating Margin6.3%
EPS$0.12
Financial Health
Debt-to-Equity9.8%
Free Cash Flow Yield-11.93%
Dividend Yield8.87%
Growth & Risk
Beta (5Y)0.44
Sharpe Ratio-0.11